Showing results (371-380 of 458) with videos related to
Sort By:
Pageof 46
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2003
A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancerCatterina Ferreccio, Maria C Bratti, Mark E Sherman, et al.Journal of the National Cancer Institute|April 11, 2023
Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine TrialBrian Befano, Nicole G Campos, Didem Egemen, et al.Journal of Clinical Microbiology|November 8, 2013
Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinicVikrant V Sahasrabuddhe, Patti E Gravitt, S Terence Dunn, et al.Gynecologic Oncology|May 27, 2023
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinomaMark Schiffman, Lisa Mirabello, Didem Egemen, et al.Journal of Lower Genital Tract Disease|January 10, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.Journal of Medical Virology|July 16, 2013
Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in TaiwanYa-Ju Chang, Hui-Chi Chen, Mei-Hung Pan, et al.American Journal of Obstetrics and Gynecology|July 13, 2002
Can cervicography be improved? An evaluation with arbitrated cervicography interpretationsDiana L Schneider, Louis Burke, Thomas C Wright, et al.Plos One|February 1, 2018
T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle studyKrystle A Lang Kuhs, Shih-Wen Lin, Xing Hua, et al.Journal of the National Cancer Institute|February 17, 2022
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and ManagementJacqueline Mix, Mona Saraiya, Benjamin D Hallowell, et al.American Journal of Obstetrics and Gynecology|December 8, 2024
Associations of obesity with post-treatment risks of cervical precancer and cancerMegan A Clarke, Brian Befano, Nicolas Wentzensen, et al.Pageof 46